Targeting evolution: Could this be the next strategy to stop superbugs?
Wednesday, November 6, 2013 - 11:00
in Biology & Nature
A researcher is among the winners of a GlaxoSmithKline (GSK) “academic drug hunter” competition that will help fast track his lab’s work to stop drug-resistant bacteria by trying to discover drugs that stop evolution of "superbugs" in its tracks.